Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Thrombosis
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Anticoagulants in thrombosis''' == * DOAC - 3/12 is shortest acceptable treatment for provoked DVT ** Apixaban 10mg BD for one week then 5mg BD ** Rivaroxaban 15mg BD for 3 weeks then 20mg daily * Warfarin preferred if: (starting dose 5mg daily in most patients) ** Weight 120kg or BMI >40 ** Weight less than 40kg ** APLS ** Mechanical heart valve ** Any contraindication to DOAC, including eGFR <30 * Warfarin starting dose 5mg daily in most patients. Need to bridge while loading for patients with VTE, until INR >2 for 2 consecutive days * Enoxaparin - primarily for cancer-related thrombosis, pregnancy and superficial vein thrombosis. 1mg/kg BD or 1.5mg/kg daily. ** Check enoxaparin anti-Xa levels in patients with renal failure, extremes of weight, suspected non-compliance or overdose. Therapeutic level (peak, 4 hours post dose) is 0.5-1.0 units/mL if on a twice daily regimen. * Unfractionated heparin ** Primarily used when rapid onset and offset is desired ** Plasma heparin anti-Xa level can be used to guide dosing in some patients: *** Failure to achieve an APTT result within the therapeutic range after 24 hours *** Heparin resistance (i.e., requirement of >35,000 units of UFH per 24 hours to achieve an APTT result within therapeutic range) *** Lupus anticoagulant (prolongs baseline APTT) *** >100kg *** Pregnant *** Need to achieve therapeutic range rapidly *** Markedly raised acute phase reactants
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thrombosis
(section)
Add topic